TriplePoint Venture Growth BDC Corp. (New York Stock Exchange:TPVG)
| Market Cap | $139.68M-45.6% |
| Revenue (ttm) | $70.41M+6.0% |
| Net Income | $21.79M-35.8% |
| EPS | $0.57-32.9% |
| Shares Out | 40.84M |
| PE Ratio | 6.00 |
| Forward PE | 4.17 |
| Dividend | $1.00(29.24%) |
| Ex-Dividend Date | Dec 16, 2026 |
| Volume | 329,531 |
| Open | $3.51 |
| Previous Close | $3.55 |
| Day's Range | $3.41 - $3.57 |
| 52-Week Range | $3.40 - $6.95 |
| Beta | 1.43 |
| Analysts | Hold |
| Price Target | $5.00(+46.20%) |
| Earnings Date | Mar 3, 2027 |
About TPVG
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
TriplePoint Venture Growth BDC Corp. Stock Analysis — InsiderScore
TriplePoint Venture Growth BDC Corp. scored higher than 25% of companies evaluated by InsiderBuying, and ranked 188th out of 253 stocks in the financials sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at TriplePoint Venture Growth BDC Corp. bought $1.48 million of stock across 1 purchase in the last 90 days, the largest of them $1.48 million.
The average purchase added about 16% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating TPVG in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Dec 16, 2026Ex-dividend date
- Mar 3, 2027Earnings report
$TPVG stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in TPVG holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by TPVG's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
TPVG Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New TPVG patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to TPVG from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in TPVG
| VPCVirtus Private Credit Strategy ETF | $187.51K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from TPVG’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
-3.5 since Sep 24Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| VPC | Virtus Private Credit Strategy ETF | 0.82% |
Weight is the stock’s share of each fund’s holdings.
